Future Health Biobank
Future Health Biobank is the UK's largest and most advanced stem cell bank, dedicated to protecting family health through innovative storage and processing of stem cells. With over 20 years of experience, they offer a wide range of services including stem cell banking, diagnostic testing, genetic screening, and more, serving families worldwide with high accreditation standards. They also provide genetic testing services such as the Vision non-invasive prenatal test and Outlook newborn screening test, which analyze DNA samples to identify potential genetic disorders and conditions.
Industries
Nr. of Employees
medium (51-250)
Future Health Biobank
Products
Non-invasive prenatal screening (NIPT) test
Clinical screening test analysing cell-free fetal DNA from maternal blood to assess risk of common fetal chromosomal aneuploidies.
Newborn genetic screening kit (buccal swab)
Single buccal swab kit for at-home newborn genetic screening covering a defined panel of inherited conditions; samples are analysed by a laboratory and results are returned to the customer.
Cord blood
Comprehensive biobanking package including cord blood, cord tissue, and placenta storage with sample collection kit, account setup, courier, maternal blood testing, full viability testing, and free release and shipment.
Cord Blood or Cord Tissue Banking Package (£1,995)
Includes first year of storage for either Cord Blood or Cord Tissue, sample collection kit, account setup, dedicated medical courier, maternal blood testing, and full viability testing.
Cord Blood and Cord Tissue Combined Banking Package (£2,695)
Comprehensive package including first year of storage for both Cord Blood and Cord Tissue, sample collection kit, account setup, and viability testing.
Cord Blood and Cord Tissue Banking with Dietary Screening Package (£2,945)
Includes cord blood and cord tissue first year of storage, full viability testing, and full dietary screening.
Non-invasive prenatal screening (NIPT) test
Clinical screening test analysing cell-free fetal DNA from maternal blood to assess risk of common fetal chromosomal aneuploidies.
Newborn genetic screening kit (buccal swab)
Single buccal swab kit for at-home newborn genetic screening covering a defined panel of inherited conditions; samples are analysed by a laboratory and results are returned to the customer.
Cord blood
Comprehensive biobanking package including cord blood, cord tissue, and placenta storage with sample collection kit, account setup, courier, maternal blood testing, full viability testing, and free release and shipment.
Cord Blood or Cord Tissue Banking Package (£1,995)
Includes first year of storage for either Cord Blood or Cord Tissue, sample collection kit, account setup, dedicated medical courier, maternal blood testing, and full viability testing.
Cord Blood and Cord Tissue Combined Banking Package (£2,695)
Comprehensive package including first year of storage for both Cord Blood and Cord Tissue, sample collection kit, account setup, and viability testing.
Cord Blood and Cord Tissue Banking with Dietary Screening Package (£2,945)
Includes cord blood and cord tissue first year of storage, full viability testing, and full dietary screening.
Services
End-to-end service for collection at birth, laboratory processing (including volume reduction), cryopreservation and long-term storage of umbilical cord blood and cord tissue for potential clinical or research use.
Collection and cryostorage of stem cells derived from exfoliated or extracted primary teeth for potential future regenerative therapies or research.
Laboratory-based screening of maternal blood for fetal chromosomal aneuploidies from ~10 weeks' gestation; samples are sent for laboratory analysis with electronic report delivery and access to genetic counselling.
At‑home buccal swab or cord-blood sample collection kit for panel-based postnatal genetic screening; samples are transported to a laboratory for analysis and results are delivered to the customer (reported turnaround up to 21 days).
Targeted genetic tests to detect predispositions relevant to diet (examples: lactose intolerance, celiac disease, taste sensitivity) delivered via sample kit and laboratory analysis.
End-to-end service for collection at birth, laboratory processing (including volume reduction), cryopreservation and long-term storage of umbilical cord blood and cord tissue for potential clinical or research use.
Collection and cryostorage of stem cells derived from exfoliated or extracted primary teeth for potential future regenerative therapies or research.
Laboratory-based screening of maternal blood for fetal chromosomal aneuploidies from ~10 weeks' gestation; samples are sent for laboratory analysis with electronic report delivery and access to genetic counselling.
At‑home buccal swab or cord-blood sample collection kit for panel-based postnatal genetic screening; samples are transported to a laboratory for analysis and results are delivered to the customer (reported turnaround up to 21 days).
Targeted genetic tests to detect predispositions relevant to diet (examples: lactose intolerance, celiac disease, taste sensitivity) delivered via sample kit and laboratory analysis.
Expertise Areas
- Stem cell biobanking (cord blood, cord tissue, dental pulp)
- Genetic screening and diagnostics (prenatal and newborn panels)
- Cryopreservation and long-term biostorage
- Cell processing and volume-reduction methods
Key Technologies
- Volume-reduction processing (RBC/plasma depletion)
- Centrifugation-based cell separation
- Sedimentation-based fractionation
- Buffy coat concentration
News & Updates
Event organized by Save the Cord Foundation to raise awareness about cord blood stem cell uses, including a free online conference on November 17.
A study investigating the potential of umbilical cord blood infusions to improve autism spectrum disorder symptoms, published in June 2020.
A review of how cord blood stem cells are transforming health through storage, marking World Cord Blood Day 2020.
A case of a 6-month-old with autism whose cord blood stem cells were stored and used for treatment.
A successful stem cell transplant for four patients with retinal damage.
Use of stem cell therapy in treating heart failure.
Event organized by Save the Cord Foundation to raise awareness about cord blood stem cell uses, including a free online conference on November 17.
A study investigating the potential of umbilical cord blood infusions to improve autism spectrum disorder symptoms, published in June 2020.
A review of how cord blood stem cells are transforming health through storage, marking World Cord Blood Day 2020.
A case of a 6-month-old with autism whose cord blood stem cells were stored and used for treatment.
A successful stem cell transplant for four patients with retinal damage.
Use of stem cell therapy in treating heart failure.